Inhibition of Complement C3 Signaling Ameliorates Locomotor and Visual Dysfunction in Autoimmune Inflammatory Diseases

Using the targeted C3 inhibitor CR2-Crry led to a significant decrease in complement deposition and demyelination in both slice cultures and focal intracerebral injection models.